AP Biosciences (ROCO:6945) OCF Margin %: 0.00% (As of Dec. 2025)


ROCO:6945 AP Biosciences Inc ROCO:6945
14 GF Score
Price NT$112.00
! 1 Warning Sign
View Full Analysis

What is AP Biosciences OCF Margin %?

AP Biosciences ROCO:6945 14 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6945 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 950 Biotechnology companies, AP Biosciences ranks worse than 105263.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. AP Biosciences's Cash Flow from Operations for the three months ended in Dec. 2025 was NT$0.00 Mil. AP Biosciences's Revenue for the three months ended in Dec. 2025 was NT$0.00 Mil. Therefore, AP Biosciences's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, AP Biosciences's current OCF Yield % is -3.22%.

The historical rank and industry rank for AP Biosciences's OCF Margin % or its related term are showing as below:


During the past 6 years, the highest OCF Margin % of AP Biosciences was -12.32%. The lowest was -2412.18%. And the median was -922.75%.

ROCO:6945's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.71
* Ranked among companies with meaningful OCF Margin % only.


AP Biosciences OCF Margin % Related Terms


AP Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for AP Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences OCF Margin % Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -2,412.18 0.00 -922.75 0.00 0.00

AP Biosciences Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6945
14GF Score
AP Biosciences Inc ROCO:6945
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AP Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

AP Biosciences's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-352.086/0
= %

AP Biosciences's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
AP Biosciences (ROCO:6945) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AP Biosciences and its competitors. According to the industry distribution chart, AP Biosciences ranks #999999 out of 950 companies in the Biotechnology industry.
Is AP Biosciences' OCF Margin % too high?
AP Biosciences' current OCF Margin % is 0.00%. Based on the distribution chart, AP Biosciences ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AP Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does AP Biosciences' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AP Biosciences ranks #999999 out of 950 companies for OCF Margin %. This places AP Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AP Biosciences and its competitors. AP Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AP Biosciences stock overvalued right now?
AP Biosciences (ROCO:6945) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. AP Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For AP Biosciences (ROCO:6945), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AP Biosciences Business Description

Address No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
14GF Score

Get the complete analysis for ROCO:6945

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$112.00
Price